Fonseca, P. E. O., Azevedo, J. A., Bié, S. M. G., & Ferreira, S. B. (2024). Benefits of using SLGT2 Inhibitors for Patients with CDK and DM2 to Reduce Mortality Risks. Archives of Pharmacy and Pharmaceutical Sciences, 8(1), 041–046. https://doi.org/10.29328/journal.apps.1001055